Otolaryngology Doctors in Waterbury, CT Accepting Medicare

7 Otolaryngology doctors found. Showing 1 - 7

Victor M Gotay, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 171 Grandview Ave, Ste 203, Waterbury, CT 06708 Phone: 203-597-1002    Fax: 203-575-9846

Dr. Christopher James Loughlin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 60 Westwood Ave, Suite 104, Waterbury, CT 06708 Phone: 203-574-5997    Fax: 203-574-5987

James Dewey Williams, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 171 Grandview Ave, Suite 201, Waterbury, CT 06708 Phone: 203-578-4630    Fax: 203-579-4629

Dr. Mahesh H. Bhaya, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21 W Main St, One Exchange Place Bldg-3rd Floor, Waterbury, CT 06702 Phone: 203-574-3777    Fax: 203-755-1708

Raymond E Winicki, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 171 Grandview Ave, Ste 201, Waterbury, CT 06708 Phone: 203-578-4630    Fax: 203-578-4629

Dr. Neil F. Schiff, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21 W Main St, One Exchange Place Building-3rd Floor, Waterbury, CT 06702 Phone: 203-574-3777    Fax: 203-755-1708

Dr. Martin Joseph Spinella, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 60 Westwood Ave, Suite 104, Waterbury, CT 06708 Phone: 203-574-4930    Fax: 203-574-5987

News Archive

UH Cleveland Medical Center explores novel treatments for uterine fibroids

Uterine fibroids, or uterine myomas, can cause symptoms that include unusually long and heavy menstrual flow, pain, enlarged uterus, pressure on the bladder and rectum, and uncomfortable intercourse.

FDA refuses Delcath's chemosaturation delivery system NDA filing

Delcath Systems, Inc. announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration for the New Drug Application for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.

SDI Pharmaceutical Company Image 2010 study: Novo Nordisk ranked top among endocrinologists

According to SDI's Pharmaceutical Company Image 2010 study, Novo Nordisk was ranked by endocrinologists as the top company overall. The company was mentioned by 62% of the endocrinologists who participated in the annual study - a substantial increase from last year, when it was mentioned by 52% of participants and ranked second.

Bats' fierce immune response to viruses could drive zoonotic emergence

It's no coincidence that some of the worst viral disease outbreaks in recent years - SARS, MERS, Ebola, Marburg and likely the newly arrived 2019-nCoV virus - originated in bats.

Stiff tissue can present microenvironment susceptible to tumor growth, says study

Stiffer breast tissue creates an environment more prone to cancer by enabling the disease to interfere with the surrounding healthy cells, according to a recent study published in Biomaterials.

Read more Medical News

› Verified 7 days ago